Viking Therapeutics Inc

Market Cap

$4B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$29.24-$6.18 (-17.45%)

Jun 8, 2026

52W High $42.0952W Low $23.09

Company Details

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype s...

CEO

—

IPO Date

Apr 29, 2015

Website

www.vikingtherapeutics.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$472M

EPS (Diluted)

Free Cash Flow

-$340M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Jul 29, 2026

PENDING

Q1 2026

Apr 30, 2026

FY 2025

Feb 11, 2026

Q4 2025

Feb 11, 2026

Q3 2025

Oct 23, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee